Lord, Abbett & Co
WGS icon

Lord, Abbett & Co’s GeneDx Holdings WGS Stock Holding History

Lord, Abbett & Co’s Portfolio WGS Stock Details WGS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-42,648
Closed -$2.74M – 636
2026
Q1 		$2.74M Sell
42,648
-475,656
-92% -$43.4M 0.01% 514
2025
Q4 		$67.4M Sell
518,304
-7,073
-1% -$971K 0.21% 129
2025
Q3 		$56.6M Buy
525,377
+90,905
+21% +$9.9M 0.17% 151
2025
Q2 		$40.1M Buy
434,472
+25,136
+6% +$1.97M 0.13% 187
2025
Q1 		$36.3M Sell
409,336
-221,137
-35% -$19.2M 0.13% 194
2024
Q4 		$48.5M Buy
+630,473
New +$44M 0.15% 173

Other funds holding WGS

CM
Corvex Management New York $3.27B AUM 38.53% 1-Year Est. Return
CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return

Lord, Abbett & Co's WGS Position: Q2 2026 in Review

Lord, Abbett & Co sold out of GeneDx Holdings (WGS) in Q2 2026, closing a stake of 42,648 shares — an estimated $2.74M sold.

Lord, Abbett & Co first reported a position in WGS in Q4 2024 and held it in 6 quarters. The position peaked at $67.4M in Q4 2025. 223 funds tracked by Wall St. Rank hold WGS as of Q2 2026.

  • Lord, Abbett & Co reported no remaining GeneDx Holdings position as of Q2 2026 after selling out during the quarter.
  • Lord, Abbett & Co sold 42,648 GeneDx Holdings shares in Q2 2026, an estimated $2.74M.
  • Lord, Abbett & Co first reported a position in GeneDx Holdings in Q4 2024 and held it in 6 quarters.
  • Lord, Abbett & Co's GeneDx Holdings position peaked at $67.4M in Q4 2025.
  • 223 funds tracked by Wall St. Rank held GeneDx Holdings as of Q2 2026.

Based on Lord, Abbett & Co's 13F filing for Q2 2026, filed 14 Aug 2026.